116 related articles for article (PubMed ID: 20826039)
1. Reprint of: Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: Programmed endosomal escape and dissociation.
Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
J Control Release; 2011 Jan; 149(1):58-64. PubMed ID: 20826039
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation.
Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
J Control Release; 2010 May; 143(3):311-7. PubMed ID: 20080139
[TBL] [Abstract][Full Text] [Related]
3. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.
Hatakeyama H; Ito E; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
J Control Release; 2009 Oct; 139(2):127-32. PubMed ID: 19540888
[TBL] [Abstract][Full Text] [Related]
4. Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for liver gene delivery.
Khalil IA; Hayashi Y; Mizuno R; Harashima H
J Control Release; 2011 Dec; 156(3):374-80. PubMed ID: 21864599
[TBL] [Abstract][Full Text] [Related]
5. The transfection activity of R8-modified nanoparticles and siRNA condensation using pH sensitive stearylated-octahistidine.
Toriyabe N; Hayashi Y; Harashima H
Biomaterials; 2013 Jan; 34(4):1337-43. PubMed ID: 23141897
[TBL] [Abstract][Full Text] [Related]
6. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape.
El-Sayed A; Masuda T; Khalil I; Akita H; Harashima H
J Control Release; 2009 Sep; 138(2):160-7. PubMed ID: 19465073
[TBL] [Abstract][Full Text] [Related]
7. A multifunctional envelope-type nanodevice for use in nanomedicine: concept and applications.
Nakamura T; Akita H; Yamada Y; Hatakeyama H; Harashima H
Acc Chem Res; 2012 Jul; 45(7):1113-21. PubMed ID: 22324902
[TBL] [Abstract][Full Text] [Related]
8. Octaarginine-modified multifunctional envelope-type nano device for siRNA.
Nakamura Y; Kogure K; Futaki S; Harashima H
J Control Release; 2007 Jun; 119(3):360-7. PubMed ID: 17478000
[TBL] [Abstract][Full Text] [Related]
9. A DNA microarray-based analysis of immune-stimulatory and transcriptional responses of dendritic cells to KALA-modified nanoparticles.
Akita H; Ishii S; Miura N; Shaheen SM; Hayashi Y; Nakamura T; Kaji N; Baba Y; Harashima H
Biomaterials; 2013 Nov; 34(35):8979-90. PubMed ID: 23968857
[TBL] [Abstract][Full Text] [Related]
10. KALA-modified multi-layered nanoparticles as gene carriers for MHC class-I mediated antigen presentation for a DNA vaccine.
Shaheen SM; Akita H; Nakamura T; Takayama S; Futaki S; Yamashita A; Katoono R; Yui N; Harashima H
Biomaterials; 2011 Sep; 32(26):6342-50. PubMed ID: 21658761
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells.
Yamada Y; Hashida M; Harashima H
Biomaterials; 2015 Jun; 52():189-98. PubMed ID: 25818425
[TBL] [Abstract][Full Text] [Related]
12. Endosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA.
Sakurai Y; Hatakeyama H; Sato Y; Akita H; Takayama K; Kobayashi S; Futaki S; Harashima H
Biomaterials; 2011 Aug; 32(24):5733-42. PubMed ID: 21605898
[TBL] [Abstract][Full Text] [Related]
13. Efficient short interference RNA delivery to tumor cells using a combination of octaarginine, GALA and tumor-specific, cleavable polyethylene glycol system.
Sakurai Y; Hatakeyama H; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
Biol Pharm Bull; 2009 May; 32(5):928-32. PubMed ID: 19420766
[TBL] [Abstract][Full Text] [Related]
14. Stearylated INF7 peptide enhances endosomal escape and gene expression of PEGylated nanoparticles both in vitro and in vivo.
El-Sayed A; Masuda T; Akita H; Harashima H
J Pharm Sci; 2012 Feb; 101(2):879-82. PubMed ID: 22086751
[TBL] [Abstract][Full Text] [Related]
15. Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid.
Hatakeyama H; Akita H; Ito E; Hayashi Y; Oishi M; Nagasaki Y; Danev R; Nagayama K; Kaji N; Kikuchi H; Baba Y; Harashima H
Biomaterials; 2011 Jun; 32(18):4306-16. PubMed ID: 21429576
[TBL] [Abstract][Full Text] [Related]
16. Ornithine and tryptophan analogs as efficient polycations for short interference RNA delivery to tumor cells.
Sato Y; Hatakeyama H; Harashima H
Biol Pharm Bull; 2010; 33(7):1246-9. PubMed ID: 20606322
[TBL] [Abstract][Full Text] [Related]
17. Advantages of ethanol dilution method for preparing GALA-modified liposomal siRNA carriers on the in vivo gene knockdown efficiency in pulmonary endothelium.
Kusumoto K; Akita H; Santiwarangkool S; Harashima H
Int J Pharm; 2014 Oct; 473(1-2):144-7. PubMed ID: 24998506
[TBL] [Abstract][Full Text] [Related]
18. A lipid nanoparticle for the efficient delivery of siRNA to dendritic cells.
Warashina S; Nakamura T; Sato Y; Fujiwara Y; Hyodo M; Hatakeyama H; Harashima H
J Control Release; 2016 Mar; 225():183-91. PubMed ID: 26820519
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment of hepatocyte growth factor gene transfer mediated by octaarginine peptide-modified nanoparticles ameliorates LPS/D-galactosamine-induced hepatitis.
Hayashi Y; Mizuno R; Ikramy KA; Akita H; Harashima H
Nucleic Acid Ther; 2012 Oct; 22(5):360-3. PubMed ID: 22963044
[TBL] [Abstract][Full Text] [Related]
20. A20 silencing by lipid envelope-type nanoparticles enhances the efficiency of lipopolysaccharide-activated dendritic cells.
Warashina S; Nakamura T; Harashima H
Biol Pharm Bull; 2011; 34(8):1348-51. PubMed ID: 21804231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
